MYROBALAN THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 05 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97111175
- Mark type
- Stylized text
- Filed
- 05 Nov 2021
- Published for opposition
- 09 Jan 2024
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of neurodegenerative diseases, demyelination diseases, schizophrenia spectrum disorders, neuropathic pain, neuroinflammation diseases, neuroexcitation disorders, immunological disorders and cancers, the pharmaceutical preparations are not derived from or containing a component of the myrobalan tree
- Class 042 — Scientific and technological services: research and development of pharmaceutical preparations not derived from or containing a component of the myrobalan tree
Owner
- Myro Therapeutics, Arlington, MA, KY
- Myro Therapeutics, Arlington, MA, KY
Prosecution history
- 04 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2026 — SOU EXTENSION 4 GRANTED
- 03 Feb 2026 — SOU EXTENSION 4 FILED
- 03 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2025 — SOU EXTENSION 3 GRANTED
- 02 Jul 2025 — SOU EXTENSION 3 FILED
- 02 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 2 GRANTED
- 09 Jan 2025 — SOU EXTENSION 2 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED